Cargando…

Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders

Celiac Disease (CD) is an immune-mediated and gluten-related disorder whose prevalence is higher in children affected with other autoimmune disorders, including diabetes mellitus type 1, autoimmune thyroiditis, and others. As regards Juvenile Idiopathic Arthritis (JIA) and other pediatric rheumatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Poddighe, Dimitri, Romano, Micol, Dossybayeva, Kuanysh, Abdukhakimova, Diyora, Galiyeva, Dinara, Demirkaya, Erkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878661/
https://www.ncbi.nlm.nih.gov/pubmed/35207358
http://dx.doi.org/10.3390/jcm11041089
_version_ 1784658712483332096
author Poddighe, Dimitri
Romano, Micol
Dossybayeva, Kuanysh
Abdukhakimova, Diyora
Galiyeva, Dinara
Demirkaya, Erkan
author_facet Poddighe, Dimitri
Romano, Micol
Dossybayeva, Kuanysh
Abdukhakimova, Diyora
Galiyeva, Dinara
Demirkaya, Erkan
author_sort Poddighe, Dimitri
collection PubMed
description Celiac Disease (CD) is an immune-mediated and gluten-related disorder whose prevalence is higher in children affected with other autoimmune disorders, including diabetes mellitus type 1, autoimmune thyroiditis, and others. As regards Juvenile Idiopathic Arthritis (JIA) and other pediatric rheumatic disorders, there is no clear recommendation for CD serological screening. In this review, we analyze all the available clinical studies investigating CD among children with JIA (and other rheumatic diseases), in order to provide objective data to better understand the necessity of CD serological screening during the follow-up. Based on the present literature review and analysis, >2.5% patients with JIA were diagnosed with CD; however, the CD prevalence in JIA patients may be even higher (>3–3.5%) due to several study limitations that could have underestimated CD diagnosis to a variable extent. Therefore, serological screening for CD in children affected with JIA could be recommended due to the increased CD prevalence in these patients (compared to the general pediatric population), and because these JIA patients diagnosed with CD were mostly asymptomatic. However, further research is needed to establish a cost-effective approach in terms of CD screening frequency and modalities during the follow-up for JIA patients. Conversely, at the moment, there is no evidence supporting a periodical CD screening in children affected with other rheumatic diseases (including pediatric systemic lupus erythematosus, juvenile dermatomyositis, and systemic sclerosis).
format Online
Article
Text
id pubmed-8878661
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88786612022-02-26 Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders Poddighe, Dimitri Romano, Micol Dossybayeva, Kuanysh Abdukhakimova, Diyora Galiyeva, Dinara Demirkaya, Erkan J Clin Med Review Celiac Disease (CD) is an immune-mediated and gluten-related disorder whose prevalence is higher in children affected with other autoimmune disorders, including diabetes mellitus type 1, autoimmune thyroiditis, and others. As regards Juvenile Idiopathic Arthritis (JIA) and other pediatric rheumatic disorders, there is no clear recommendation for CD serological screening. In this review, we analyze all the available clinical studies investigating CD among children with JIA (and other rheumatic diseases), in order to provide objective data to better understand the necessity of CD serological screening during the follow-up. Based on the present literature review and analysis, >2.5% patients with JIA were diagnosed with CD; however, the CD prevalence in JIA patients may be even higher (>3–3.5%) due to several study limitations that could have underestimated CD diagnosis to a variable extent. Therefore, serological screening for CD in children affected with JIA could be recommended due to the increased CD prevalence in these patients (compared to the general pediatric population), and because these JIA patients diagnosed with CD were mostly asymptomatic. However, further research is needed to establish a cost-effective approach in terms of CD screening frequency and modalities during the follow-up for JIA patients. Conversely, at the moment, there is no evidence supporting a periodical CD screening in children affected with other rheumatic diseases (including pediatric systemic lupus erythematosus, juvenile dermatomyositis, and systemic sclerosis). MDPI 2022-02-18 /pmc/articles/PMC8878661/ /pubmed/35207358 http://dx.doi.org/10.3390/jcm11041089 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Poddighe, Dimitri
Romano, Micol
Dossybayeva, Kuanysh
Abdukhakimova, Diyora
Galiyeva, Dinara
Demirkaya, Erkan
Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
title Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
title_full Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
title_fullStr Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
title_full_unstemmed Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
title_short Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
title_sort celiac disease in juvenile idiopathic arthritis and other pediatric rheumatic disorders
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878661/
https://www.ncbi.nlm.nih.gov/pubmed/35207358
http://dx.doi.org/10.3390/jcm11041089
work_keys_str_mv AT poddighedimitri celiacdiseaseinjuvenileidiopathicarthritisandotherpediatricrheumaticdisorders
AT romanomicol celiacdiseaseinjuvenileidiopathicarthritisandotherpediatricrheumaticdisorders
AT dossybayevakuanysh celiacdiseaseinjuvenileidiopathicarthritisandotherpediatricrheumaticdisorders
AT abdukhakimovadiyora celiacdiseaseinjuvenileidiopathicarthritisandotherpediatricrheumaticdisorders
AT galiyevadinara celiacdiseaseinjuvenileidiopathicarthritisandotherpediatricrheumaticdisorders
AT demirkayaerkan celiacdiseaseinjuvenileidiopathicarthritisandotherpediatricrheumaticdisorders